Skip to main content

Table 1 Baseline clinical characteristics and cardiac ultrasound indicators in the control and MHD groups

From: Left ventricular geometry characteristics and clinical outcomes in hemodialysis patients with heart failure with preserved ejection fraction

 

Control(n = 60)

MHD patients(n = 210)

P/X2

Sex, female, n(%)

30(50%)

104(49.5%)

0.53

Age

55.7 ± 12.3

55.3 ± 9.9

0.84

BMI

22.92 ± 2.52

23.16 ± 3.46

0.62

SBP, mmHg

115.6 ± 7.5

146.22 ± 20.39

<0.01

DBP, mmHg

74.2 ± 5.69

80.67 ± 13.31

<0.01

HR, bpm

68.94 ± 11.42

74.24 ± 13.3

0.01

Hemoglobin, g/L

136.06 ± 15.92

101.06 ± 16.84

<0.01

Alb, g/L

43.1 ± 7.51

40.03 ± 4.57

<0.01

Ca, mmol/L

2.43 ± 0.19

2.26 ± 0.21

<0.01

P, mmol/L

1.09 ± 0.14

1.69 ± 0.52

<0.01

PTH, pg/mL

44.87(40.23–49.50)

200.32(168.28-232.37)

<0.01

hs-CRP, mg/dl

0.14(0.12–0.17)

0.36(0.28–0.44)

0.01

TC, mmol/L

3.86 ± 0.88

3.83 ± 1.13

0.86

Triglyceride, mmol/La

1.27 ± 0.31

1.54 ± 1.21

0.09

LDL, mmol/L

1.93 ± 0.8

2.19 ± 0.74

0.02

HDL, mmol/L

1.37 ± 0.21

1.1 ± 0.39

<0.01

TNI, ng/L

0.01 ± 0.03

0.04 ± 0.21

0.35

BNP*

2.33 ± 0.59

2.73 ± 0.66

<0.01

UF, L

 

2.74 ± 0.76

<0.01

Scr, umol/L

54.47(58.56–7.34)

690.2(635.76-744.64)

<0.01

Echocardiographic characteristics

   

LAD, cm

3.41 ± 0.47

3.78 ± 0.59

<0.01

LVEDd, cm

4.31 ± 0.55

4.53 ± 0.57

<0.01

RAD, cm

3.37 ± 0.47

3.34 ± 0.58

0.705

RVD, cm

3.22 ± 0.47

3.25 ± 0.49

0.671

IVST, cm

1.12 ± 0.15

1.21 ± 0.19

<0.01

LVPW, cm

1.08 ± 0.14

1.16 ± 0.16

0.002

LVEDVi, ml/ m2

48.85 ± 11.99

52.83 ± 18.33

0.12

LVESVi, ml/ m2

17.78 ± 5.77

19.46 ± 8.8

0.11

COi, L/min/ m2

2.23 ± 0.54

2.4 ± 0.74

0.11

RWT

0.45 ± 0.08

0.51 ± 0.09

<0.01

LVMi, g/m2

97.8 ± 13.23

132.42 ± 36.23

<0.01

Systolic function

   

LVEF,%

64.18 ± 5.4

63.76 ± 5.24

0.59

LVGLS,%

-19.72 ± 2.97

-16.46 ± 3.43

<0.01

LVGCS,%

-23.76 ± 5.02

-21.95 ± 5.55

0.03

LVGRS,%

-41.98 ± 6.41

-31.85 ± 16.73

<0.01

Diastolic function

   

E/A ratio

1.03 ± 0.38

0.87 ± 0.37

<0.01

E/e’ ratio (septal)

8.72 ± 2.63

12.72 ± 5.08

<0.01

LAVi, ml/m2

24.08 ± 7.18

31.01 ± 13.63

<0.01

Right ventricular function

   

FAC,%

49.78 ± 9.02

49.03 ± 8.01

0.53

TAPSE, cm

2.15 ± 0.27

2.16 ± 0.36

0.83

RVGLS,%

-26.31 ± 5.32

-26.98 ± 6.35

0.46

  1. Values are expressed as n, mean ± SD, n (%),or median (interquartile range), unless otherwise indicated
  2. Abbreviations: Alb, albumin; ADQI, The Acute Dialysis Quality Initiative Workgroup; AVF, arteriovenous fistula; BMI, body mass index; BNP*,BNP-After logarithmic conversion; Ca, calcium; COi, cardiac output index; DBP, diastolic blood pressure; E/A, peak early diastolic transmitral flow velocity/peak late diastolic transmitral flow velocity; E/e′,peak early diastolic transmitral flow velocity/peak early diastolic mitral annular tissue velocity; HR, heart rate; HDL, high-density lipoprotein cholesterol; hs-CRP, high sensitivity C-reactive protein; LAD, left atrial diameter; LDL, low-density lipoprotein cholesterol; LVEDd, left ventricular end-diastolic diameters; IVST, interventricular septal thickness; LVPW, left ventricular posterior wall thickness; LVEDVi, left ventricular end-diastolic volume index; LVMI, left ventricular mass index; LVEF, left ventricular ejection fraction; LVGLS, left ventricular global longitudinal strain; LVGCS, left ventricular global circumferential strain; LVGRS, left ventricular global radial strain; LVESVi, left ventricular end-systolic volume index; LAVi, left atrial volume index; P,phosphorus; PTH, parathyroid hormone; SBP, systolic blood pressure; RVFAC, right ventricular fractional area change; RAD, right atrial diameter; RASI, renin-angiotensin aldosterone system inhibitor; RVD, right ventricular diameter; RWT, relative wall thickness; RVGLS, right ventricular global longitudinal strain; TAPSE, tricuspid annular plane systolic excursio; TC, total cholesterol; TNI, troponin I; UF, ultrafiltration
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us